No long-term survival benefit with sustained-release 5-fluorouracil implants in patients with stages II and III gastric cancer

BACKGROUND: The prognosis of gastric cancer in an advanced stage remains poor. The exact efficacy of the use of intraoperative sustained-release chemotherapy with 5-fluorouracil (5-FU) in advanced-stage gastric cancer is still unelucidated. AIM: To explore the long-term survival benefit of using sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Yun-Zi, Wu, Ming, Zheng, Xiao-Hao, Wang, Bing-Zhi, Xue, Li-Yan, Ding, Shi-Kang, Yang, Lin, Ren, Jian-Song, Tian, Yan-Tao, Xie, Yi-Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Retrospective Cohort Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594009/
https://www.ncbi.nlm.nih.gov/pubmed/36304092
http://dx.doi.org/10.3748/wjg.v28.i38.5589

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9594009/
https://www.ncbi.nlm.nih.gov/pubmed/36304092
http://dx.doi.org/10.3748/wjg.v28.i38.5589

Ejemplares similares